Cyclerion Therapeutics, Inc. (CYCN)
NGS · Common · CUSIP 23255M105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CYCN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
23255M105
Market Cap
Small Cap
Business: Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Cyclerion plans to advance its current portfolio of five differentiated sGC stimulator programs with distinct pharmacologic and biodistribution properties that are uniquely designed to target tissues of greatest relevance to the diseases they are intended to treat.

Company Contact

CEO
Regina Graul
CFO
Rhonda Chicko
Headquarters
245 First Street, 18th Floor, Cambridge, MA 02142
Phone
857-327-8778
Investor Relations
Carlo Tanzi, Kendal IR · ctanzi@kendallir.com
General Email
IR@cyclerion.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »